Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
in vivo CAR-T
Biotech
ArsenalBio sheds most of staff in pivot to in vivo CAR-T
About a year after halving its staff in a clinical push, ArsenalBio is now making a hard pivot that involves laying off most of its employees.
Darren Incorvaia
Sep 1, 2026 9:59am
J&J pays Sail $785M, securing option on in vivo CAR-T buyout
Jul 30, 2026 5:30am
Moderna enters in vivo CAR-T with autoimmune asset
Jun 26, 2026 9:00am
ASCO: Lilly's faith in Kelonia rewarded with ‘nutty’ CAR-T data
May 31, 2026 8:00am
Create Medicines fashions $122M raise for in vivo CAR-T dreams
May 14, 2026 9:42am
Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts
Apr 28, 2026 3:21am
